Bayer: Endometriosis trials

The registry lists 27 Endometriosis studies with Bayer as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 10Phase 2 6Phase 3 4No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the WombTerminatedNCT04614246Phase 2Results posted
• Assess Safety and Efficacy of Vilaprisan in Subjects With EndometriosisTerminatedNCT03573336Phase 2Results posted
• Bay98-7196, Dose Finding / POC StudyCompletedNCT02203331Phase 2Results posted
• Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male ParticipantsCompletedNCT05517746Phase 1
• A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female ParticipantsCompletedNCT04851483Phase 1
• A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With EndometriosisCompletedNCT04808843
• A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese ParticipantsCompletedNCT04495855
• Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female ParticipantsCompletedNCT04423744Phase 1
• Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.CompletedNCT04027192Phase 1
• A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the VeinCompletedNCT03773068Phase 1
• BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food EffectCompletedNCT03427788Phase 1
• Pharmacokinetics and Safety of Vilaprisan in Renal ImpairmentCompletedNCT03411980Phase 1
• A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work BestTerminatedNCT03373422Phase 2
• Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or DysmenorrheaCompletedNCT03126747
• Drug-drug Interaction Study Between Orally Administered Rifampicin and VilaprisanCompletedNCT02975440Phase 1
• Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal RingCompletedNCT02545452Phase 1
• Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy WomenCompletedNCT02434640Phase 1
• To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With EndometriosisCompletedNCT02425462
• Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese PatientsCompletedNCT01822080Phase 3
• Regulatory Post Marketing Surveillance Study in KoreaCompletedNCT01788722
• Comparative Study of BAY86-5300 With an Extended Flexible Regimen for EndometriosisCompletedNCT01697111Phase 3
• Validation Study for Endometriosis PROCompletedNCT01643122
• Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of LifeCompletedNCT01595724
• Visanne Study to Assess Safety in AdolescentsCompletedNCT01283724Phase 2
• Efficacy and Safety of SH T00660AA in Treatment of EndometriosisCompletedNCT00225199Phase 3
• Safety and Efficacy of SH T00660AA in Treatment of EndometriosisCompletedNCT00225186Phase 3
• Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic PainCompletedNCT00185341Phase 2